Global Recombinant Erythropoietin Market Growth (Status and Outlook) 2023-2029

March 2023 | 104 pages | ID: GA4DE012B85DEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Recombinant Erythropoietin Industry Forecast” looks at past sales and reviews total world Recombinant Erythropoietin sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Erythropoietin sales for 2023 through 2029. With Recombinant Erythropoietin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Erythropoietin industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Erythropoietin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Erythropoietin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Erythropoietin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Erythropoietin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Erythropoietin.

The global Recombinant Erythropoietin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Recombinant Erythropoietin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Recombinant Erythropoietin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Recombinant Erythropoietin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Recombinant Erythropoietin players cover Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Roche, 3SBio Group, Celltrion, Inc, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd and LG Life Sciences Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Erythropoietin market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• rhEPO
• Erythropoiesis-Stimulating Agents (ESA)

Segmentation by application

• Chronic Kidney Disease
• Cancer Related Anemia
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Amgen
• Johnson & Johnson
• Kyowa Hakko Kirin
• Roche
• 3SBio Group
• Celltrion, Inc
• Teva Pharmaceutical Industries Ltd
• F. Hoffmann-La Roche Ltd
• LG Life Sciences Ltd
• Biocon Limited
• Intas Pharmaceuticals Ltd
• Sun Pharmaceutical Industries Ltd
• Dr. Reddy's Laboratories Ltd

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Recombinant Erythropoietin Market Size 2018-2029
  2.1.2 Recombinant Erythropoietin Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Recombinant Erythropoietin Segment by Type
  2.2.1 rhEPO
  2.2.2 Erythropoiesis-Stimulating Agents (ESA)
2.3 Recombinant Erythropoietin Market Size by Type
  2.3.1 Recombinant Erythropoietin Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Recombinant Erythropoietin Market Size Market Share by Type (2018-2023)
2.4 Recombinant Erythropoietin Segment by Application
  2.4.1 Chronic Kidney Disease
  2.4.2 Cancer Related Anemia
  2.4.3 Others
2.5 Recombinant Erythropoietin Market Size by Application
  2.5.1 Recombinant Erythropoietin Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Recombinant Erythropoietin Market Size Market Share by Application (2018-2023)

3 RECOMBINANT ERYTHROPOIETIN MARKET SIZE BY PLAYER

3.1 Recombinant Erythropoietin Market Size Market Share by Players
  3.1.1 Global Recombinant Erythropoietin Revenue by Players (2018-2023)
  3.1.2 Global Recombinant Erythropoietin Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant Erythropoietin Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RECOMBINANT ERYTHROPOIETIN BY REGIONS

4.1 Recombinant Erythropoietin Market Size by Regions (2018-2023)
4.2 Americas Recombinant Erythropoietin Market Size Growth (2018-2023)
4.3 APAC Recombinant Erythropoietin Market Size Growth (2018-2023)
4.4 Europe Recombinant Erythropoietin Market Size Growth (2018-2023)
4.5 Middle East & Africa Recombinant Erythropoietin Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Recombinant Erythropoietin Market Size by Country (2018-2023)
5.2 Americas Recombinant Erythropoietin Market Size by Type (2018-2023)
5.3 Americas Recombinant Erythropoietin Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Recombinant Erythropoietin Market Size by Region (2018-2023)
6.2 APAC Recombinant Erythropoietin Market Size by Type (2018-2023)
6.3 APAC Recombinant Erythropoietin Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Recombinant Erythropoietin by Country (2018-2023)
7.2 Europe Recombinant Erythropoietin Market Size by Type (2018-2023)
7.3 Europe Recombinant Erythropoietin Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Recombinant Erythropoietin by Region (2018-2023)
8.2 Middle East & Africa Recombinant Erythropoietin Market Size by Type (2018-2023)
8.3 Middle East & Africa Recombinant Erythropoietin Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RECOMBINANT ERYTHROPOIETIN MARKET FORECAST

10.1 Global Recombinant Erythropoietin Forecast by Regions (2024-2029)
  10.1.1 Global Recombinant Erythropoietin Forecast by Regions (2024-2029)
  10.1.2 Americas Recombinant Erythropoietin Forecast
  10.1.3 APAC Recombinant Erythropoietin Forecast
  10.1.4 Europe Recombinant Erythropoietin Forecast
  10.1.5 Middle East & Africa Recombinant Erythropoietin Forecast
10.2 Americas Recombinant Erythropoietin Forecast by Country (2024-2029)
  10.2.1 United States Recombinant Erythropoietin Market Forecast
  10.2.2 Canada Recombinant Erythropoietin Market Forecast
  10.2.3 Mexico Recombinant Erythropoietin Market Forecast
  10.2.4 Brazil Recombinant Erythropoietin Market Forecast
10.3 APAC Recombinant Erythropoietin Forecast by Region (2024-2029)
  10.3.1 China Recombinant Erythropoietin Market Forecast
  10.3.2 Japan Recombinant Erythropoietin Market Forecast
  10.3.3 Korea Recombinant Erythropoietin Market Forecast
  10.3.4 Southeast Asia Recombinant Erythropoietin Market Forecast
  10.3.5 India Recombinant Erythropoietin Market Forecast
  10.3.6 Australia Recombinant Erythropoietin Market Forecast
10.4 Europe Recombinant Erythropoietin Forecast by Country (2024-2029)
  10.4.1 Germany Recombinant Erythropoietin Market Forecast
  10.4.2 France Recombinant Erythropoietin Market Forecast
  10.4.3 UK Recombinant Erythropoietin Market Forecast
  10.4.4 Italy Recombinant Erythropoietin Market Forecast
  10.4.5 Russia Recombinant Erythropoietin Market Forecast
10.5 Middle East & Africa Recombinant Erythropoietin Forecast by Region (2024-2029)
  10.5.1 Egypt Recombinant Erythropoietin Market Forecast
  10.5.2 South Africa Recombinant Erythropoietin Market Forecast
  10.5.3 Israel Recombinant Erythropoietin Market Forecast
  10.5.4 Turkey Recombinant Erythropoietin Market Forecast
  10.5.5 GCC Countries Recombinant Erythropoietin Market Forecast
10.6 Global Recombinant Erythropoietin Forecast by Type (2024-2029)
10.7 Global Recombinant Erythropoietin Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Amgen
  11.1.1 Amgen Company Information
  11.1.2 Amgen Recombinant Erythropoietin Product Offered
  11.1.3 Amgen Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Amgen Main Business Overview
  11.1.5 Amgen Latest Developments
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Information
  11.2.2 Johnson & Johnson Recombinant Erythropoietin Product Offered
  11.2.3 Johnson & Johnson Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Johnson & Johnson Main Business Overview
  11.2.5 Johnson & Johnson Latest Developments
11.3 Kyowa Hakko Kirin
  11.3.1 Kyowa Hakko Kirin Company Information
  11.3.2 Kyowa Hakko Kirin Recombinant Erythropoietin Product Offered
  11.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Kyowa Hakko Kirin Main Business Overview
  11.3.5 Kyowa Hakko Kirin Latest Developments
11.4 Roche
  11.4.1 Roche Company Information
  11.4.2 Roche Recombinant Erythropoietin Product Offered
  11.4.3 Roche Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Roche Main Business Overview
  11.4.5 Roche Latest Developments
11.5 3SBio Group
  11.5.1 3SBio Group Company Information
  11.5.2 3SBio Group Recombinant Erythropoietin Product Offered
  11.5.3 3SBio Group Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 3SBio Group Main Business Overview
  11.5.5 3SBio Group Latest Developments
11.6 Celltrion, Inc
  11.6.1 Celltrion, Inc Company Information
  11.6.2 Celltrion, Inc Recombinant Erythropoietin Product Offered
  11.6.3 Celltrion, Inc Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Celltrion, Inc Main Business Overview
  11.6.5 Celltrion, Inc Latest Developments
11.7 Teva Pharmaceutical Industries Ltd
  11.7.1 Teva Pharmaceutical Industries Ltd Company Information
  11.7.2 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Offered
  11.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview
  11.7.5 Teva Pharmaceutical Industries Ltd Latest Developments
11.8 F. Hoffmann-La Roche Ltd
  11.8.1 F. Hoffmann-La Roche Ltd Company Information
  11.8.2 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Product Offered
  11.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 F. Hoffmann-La Roche Ltd Main Business Overview
  11.8.5 F. Hoffmann-La Roche Ltd Latest Developments
11.9 LG Life Sciences Ltd
  11.9.1 LG Life Sciences Ltd Company Information
  11.9.2 LG Life Sciences Ltd Recombinant Erythropoietin Product Offered
  11.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 LG Life Sciences Ltd Main Business Overview
  11.9.5 LG Life Sciences Ltd Latest Developments
11.10 Biocon Limited
  11.10.1 Biocon Limited Company Information
  11.10.2 Biocon Limited Recombinant Erythropoietin Product Offered
  11.10.3 Biocon Limited Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Biocon Limited Main Business Overview
  11.10.5 Biocon Limited Latest Developments
11.11 Intas Pharmaceuticals Ltd
  11.11.1 Intas Pharmaceuticals Ltd Company Information
  11.11.2 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Product Offered
  11.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Intas Pharmaceuticals Ltd Main Business Overview
  11.11.5 Intas Pharmaceuticals Ltd Latest Developments
11.12 Sun Pharmaceutical Industries Ltd
  11.12.1 Sun Pharmaceutical Industries Ltd Company Information
  11.12.2 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Offered
  11.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Sun Pharmaceutical Industries Ltd Main Business Overview
  11.12.5 Sun Pharmaceutical Industries Ltd Latest Developments
11.13 Dr. Reddy's Laboratories Ltd
  11.13.1 Dr. Reddy's Laboratories Ltd Company Information
  11.13.2 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Product Offered
  11.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Dr. Reddy's Laboratories Ltd Main Business Overview
  11.13.5 Dr. Reddy's Laboratories Ltd Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Recombinant Erythropoietin Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of rhEPO
Table 3. Major Players of Erythropoiesis-Stimulating Agents (ESA)
Table 4. Recombinant Erythropoietin Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Recombinant Erythropoietin Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Recombinant Erythropoietin Market Size Market Share by Type (2018-2023)
Table 7. Recombinant Erythropoietin Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Recombinant Erythropoietin Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Recombinant Erythropoietin Market Size Market Share by Application (2018-2023)
Table 10. Global Recombinant Erythropoietin Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Recombinant Erythropoietin Revenue Market Share by Player (2018-2023)
Table 12. Recombinant Erythropoietin Key Players Head office and Products Offered
Table 13. Recombinant Erythropoietin Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Recombinant Erythropoietin Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Recombinant Erythropoietin Market Size Market Share by Regions (2018-2023)
Table 18. Global Recombinant Erythropoietin Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Recombinant Erythropoietin Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Recombinant Erythropoietin Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Recombinant Erythropoietin Market Size Market Share by Country (2018-2023)
Table 22. Americas Recombinant Erythropoietin Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Recombinant Erythropoietin Market Size Market Share by Type (2018-2023)
Table 24. Americas Recombinant Erythropoietin Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Recombinant Erythropoietin Market Size Market Share by Application (2018-2023)
Table 26. APAC Recombinant Erythropoietin Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Recombinant Erythropoietin Market Size Market Share by Region (2018-2023)
Table 28. APAC Recombinant Erythropoietin Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Recombinant Erythropoietin Market Size Market Share by Type (2018-2023)
Table 30. APAC Recombinant Erythropoietin Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Recombinant Erythropoietin Market Size Market Share by Application (2018-2023)
Table 32. Europe Recombinant Erythropoietin Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Recombinant Erythropoietin Market Size Market Share by Country (2018-2023)
Table 34. Europe Recombinant Erythropoietin Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Recombinant Erythropoietin Market Size Market Share by Type (2018-2023)
Table 36. Europe Recombinant Erythropoietin Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Recombinant Erythropoietin Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Recombinant Erythropoietin Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Recombinant Erythropoietin Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Recombinant Erythropoietin Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Recombinant Erythropoietin
Table 45. Key Market Challenges & Risks of Recombinant Erythropoietin
Table 46. Key Industry Trends of Recombinant Erythropoietin
Table 47. Global Recombinant Erythropoietin Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Recombinant Erythropoietin Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Recombinant Erythropoietin Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Recombinant Erythropoietin Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Amgen Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 52. Amgen Recombinant Erythropoietin Product Offered
Table 53. Amgen Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Amgen Main Business
Table 55. Amgen Latest Developments
Table 56. Johnson & Johnson Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 57. Johnson & Johnson Recombinant Erythropoietin Product Offered
Table 58. Johnson & Johnson Main Business
Table 59. Johnson & Johnson Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Johnson & Johnson Latest Developments
Table 61. Kyowa Hakko Kirin Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 62. Kyowa Hakko Kirin Recombinant Erythropoietin Product Offered
Table 63. Kyowa Hakko Kirin Main Business
Table 64. Kyowa Hakko Kirin Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Kyowa Hakko Kirin Latest Developments
Table 66. Roche Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 67. Roche Recombinant Erythropoietin Product Offered
Table 68. Roche Main Business
Table 69. Roche Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Roche Latest Developments
Table 71. 3SBio Group Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 72. 3SBio Group Recombinant Erythropoietin Product Offered
Table 73. 3SBio Group Main Business
Table 74. 3SBio Group Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. 3SBio Group Latest Developments
Table 76. Celltrion, Inc Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 77. Celltrion, Inc Recombinant Erythropoietin Product Offered
Table 78. Celltrion, Inc Main Business
Table 79. Celltrion, Inc Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Celltrion, Inc Latest Developments
Table 81. Teva Pharmaceutical Industries Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 82. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Offered
Table 83. Teva Pharmaceutical Industries Ltd Main Business
Table 84. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Teva Pharmaceutical Industries Ltd Latest Developments
Table 86. F. Hoffmann-La Roche Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 87. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Product Offered
Table 88. F. Hoffmann-La Roche Ltd Main Business
Table 89. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. F. Hoffmann-La Roche Ltd Latest Developments
Table 91. LG Life Sciences Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 92. LG Life Sciences Ltd Recombinant Erythropoietin Product Offered
Table 93. LG Life Sciences Ltd Main Business
Table 94. LG Life Sciences Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. LG Life Sciences Ltd Latest Developments
Table 96. Biocon Limited Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 97. Biocon Limited Recombinant Erythropoietin Product Offered
Table 98. Biocon Limited Main Business
Table 99. Biocon Limited Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Biocon Limited Latest Developments
Table 101. Intas Pharmaceuticals Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 102. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Product Offered
Table 103. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Intas Pharmaceuticals Ltd Main Business
Table 105. Intas Pharmaceuticals Ltd Latest Developments
Table 106. Sun Pharmaceutical Industries Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 107. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Offered
Table 108. Sun Pharmaceutical Industries Ltd Main Business
Table 109. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Sun Pharmaceutical Industries Ltd Latest Developments
Table 111. Dr. Reddy's Laboratories Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors
Table 112. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Product Offered
Table 113. Dr. Reddy's Laboratories Ltd Main Business
Table 114. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Dr. Reddy's Laboratories Ltd Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Erythropoietin Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Erythropoietin Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Recombinant Erythropoietin Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Recombinant Erythropoietin Sales Market Share by Country/Region (2022)
Figure 8. Recombinant Erythropoietin Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Recombinant Erythropoietin Market Size Market Share by Type in 2022
Figure 10. Recombinant Erythropoietin in Chronic Kidney Disease
Figure 11. Global Recombinant Erythropoietin Market: Chronic Kidney Disease (2018-2023) & ($ Millions)
Figure 12. Recombinant Erythropoietin in Cancer Related Anemia
Figure 13. Global Recombinant Erythropoietin Market: Cancer Related Anemia (2018-2023) & ($ Millions)
Figure 14. Recombinant Erythropoietin in Others
Figure 15. Global Recombinant Erythropoietin Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Recombinant Erythropoietin Market Size Market Share by Application in 2022
Figure 17. Global Recombinant Erythropoietin Revenue Market Share by Player in 2022
Figure 18. Global Recombinant Erythropoietin Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Recombinant Erythropoietin Market Size 2018-2023 ($ Millions)
Figure 20. APAC Recombinant Erythropoietin Market Size 2018-2023 ($ Millions)
Figure 21. Europe Recombinant Erythropoietin Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Recombinant Erythropoietin Market Size 2018-2023 ($ Millions)
Figure 23. Americas Recombinant Erythropoietin Value Market Share by Country in 2022
Figure 24. United States Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Recombinant Erythropoietin Market Size Market Share by Region in 2022
Figure 29. APAC Recombinant Erythropoietin Market Size Market Share by Type in 2022
Figure 30. APAC Recombinant Erythropoietin Market Size Market Share by Application in 2022
Figure 31. China Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Recombinant Erythropoietin Market Size Market Share by Country in 2022
Figure 38. Europe Recombinant Erythropoietin Market Size Market Share by Type (2018-2023)
Figure 39. Europe Recombinant Erythropoietin Market Size Market Share by Application (2018-2023)
Figure 40. Germany Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Recombinant Erythropoietin Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 54. APAC Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 55. Europe Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 57. United States Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 58. Canada Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 61. China Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 62. Japan Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 63. Korea Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 65. India Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 66. Australia Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 67. Germany Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 68. France Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 69. UK Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 70. Italy Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 71. Russia Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 72. Spain Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 75. Israel Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Recombinant Erythropoietin Market Size 2024-2029 ($ Millions)
Figure 78. Global Recombinant Erythropoietin Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Erythropoietin Market Size Market Share Forecast by Application (2024-2029)